ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,066.00
-0.07%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36175
0.02%
Bitcoin
66,771.26
2.35%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. OptiNose Inc (OPTN)

  7. OptiNose Inc (OPTN) News

OPTN

OptiNose (OPTN)

OptiNose Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPTN
DateTimeSourceHeadlineSymbolCompany
05/17/202411:00AMGlobeNewswire Inc.Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:OPTNOptiNose Inc
05/14/20248:01AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPTNOptiNose Inc
05/14/20246:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
05/14/20246:00AMGlobeNewswire Inc.Optinose Reports First Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
05/10/20241:56PMGlobeNewswire Inc.Optinose Announces Reporting Date for First Quarter 2024 Financial ResultsNASDAQ:OPTNOptiNose Inc
05/09/20246:09AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPTNOptiNose Inc
05/09/20246:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
05/09/20246:03AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPTNOptiNose Inc
05/09/20246:02AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPTNOptiNose Inc
05/09/20246:00AMGlobeNewswire Inc.Optinose Announces $55 Million Registered Direct OfferingNASDAQ:OPTNOptiNose Inc
04/25/20246:00AMGlobeNewswire Inc.Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 millionNASDAQ:OPTNOptiNose Inc
04/04/20243:01PMGlobeNewswire Inc.Optinose to Present at the Needham Virtual Healthcare ConferenceNASDAQ:OPTNOptiNose Inc
03/15/20242:34PMGlobeNewswire Inc.XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal PolypsNASDAQ:OPTNOptiNose Inc
03/08/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
03/07/20243:32PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OPTNOptiNose Inc
03/07/20246:01AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OPTNOptiNose Inc
03/07/20246:00AMGlobeNewswire Inc.Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
03/07/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
02/29/20243:40PMGlobeNewswire Inc.Optinose Announces Reporting Date for Fourth Quarter 2023 Financial ResultsNASDAQ:OPTNOptiNose Inc
02/29/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
02/29/20243:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
02/29/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
02/29/20243:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
02/23/20246:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
02/22/20243:28PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OPTNOptiNose Inc
02/14/20247:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OPTNOptiNose Inc
02/13/20244:16PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OPTNOptiNose Inc
02/01/20241:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
01/30/20243:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OPTNOptiNose Inc
01/18/202411:00AMGlobeNewswire Inc.Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In PracticeNASDAQ:OPTNOptiNose Inc
 Showing the most relevant articles for your search:NASDAQ:OPTN

Your Recent History

NYSE
MSGR
Direxion Shares
TSX
VGAB
Vanguard Global Aggregat...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved